Roshal R. Patel

MathematicsEconomics, Econometrics and FinanceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 19 papers. Top paper: “Role of Mitochondria in Cancer Immune Evasion and Potential Therapeutic Approaches”.

Role of Mitochondria in Cancer Immune Evasion and Potential Therapeutic Approaches

Frontiers in Immunology(2020)10.3389/fimmu.2020.573326

N/A

0.729DataRank · unranked

128 citations

Kewen He, Ahmed Younes, Hampartsoum B. Barsoumian, Dawei Chen, Tugce Ozgen +8 more

The radiotherapy quality assurance gap among phase III cancer clinical trials

Radiotherapy and Oncology(2021)10.1016/j.radonc.2021.11.018

N/A

0.520DataRank · unranked

31 citations

Stephen F. Kry, Rebecca M. Howell, Ramez Kouzy, Joseph Abi Jaoude, Roshal R. Patel +12 more

Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy

European Journal of Cancer(2023)10.1016/j.ejca.2023.113357

N/A

0.449DataRank · unranked

19 citations

Pavlos Msaouel, Zachary R. McCaw, Joseph Abi Jaoude, Eric J. Hsu, Ramez Kouzy +13 more

Prevalence, trends, and characteristics of trials investigating local therapy in contemporary phase 3 clinical cancer research

Cancer(2023)10.1002/cncr.34929

N/A

0.425DataRank · unranked

16 citations

Kelsey L. Corrigan, Ramez Kouzy, Joseph Abi Jaoude, Yumeng Yang, Roshal R. Patel +9 more

Association of differential censoring with survival and suboptimal control arms among oncology clinical trials

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae028

N/A

0.360DataRank · unranked

10 citations

Timothy A. Lin, Dor Reuven Dabush, Zachary R. McCaw, Alex Koong, Christine Lin +19 more

Food and Drug Administration approvals in phase 3 Cancer clinical trials

BMC Cancer(2021)10.1186/s12885-021-08457-5

N/A

0DataRank · unranked

27 citations

Ramez Kouzy, Marc Ghabach, Roshal R. Patel, Dario Pasalic, Elie Ghossain +9 more

Pulsed Radiation Therapy to Improve Systemic Control of Metastatic Cancer

Frontiers in Oncology(2021)10.3389/fonc.2021.737425

N/A

0DataRank · unranked

19 citations

Hampartsoum B. Barsoumian, Duygu Sezen, Nahum Puebla‐Osorio, Ethan Hsu, Vivek Verma +7 more

Impact factor and citation metrics in phase III cancer trials

Oncotarget(2021)10.18632/oncotarget.28044

N/A

0DataRank · unranked

8 citations

Ramez Kouzy, Michael K. Rooney, Petria Thompson, Roshal R. Patel, Maddie C. Turner +6 more

Inclusion of premenopausal women in breast cancer clinical trials

The Breast(2022)10.1016/j.breast.2022.10.013

N/A

0DataRank · unranked

4 citations

Ramez Kouzy, Joseph Abi Jaoude, Roshal R. Patel, Rachel M. Layman, Sharon H. Giordano +5 more

Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.13819

N/A

0DataRank · unranked

12 citations

Joseph Abi Jaoude, Roshal R. Patel, Ramez Kouzy, Timothy A. Lin, Brian De +11 more

Proportional Hazards Violations in Phase III Cancer Clinical Trials: A Potential Source of Trial Misinterpretation

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0566

N/A

0DataRank · unranked

13 citations

Zachary R. McCaw, Alex Koong, Christine Lin, Joseph Abi Jaoude, Roshal R. Patel +14 more

Towards Treatment Effect Interpretability: A Bayesian Re-analysis of 194,129 Patient Outcomes Across 230 Oncology Trials

medRxiv(2024)10.1101/2024.07.23.24310891

N/A

0DataRank · unranked

3 citations

Pavlos Msaouel, Gabrielle S. Kupferman, Timothy A. Lin, Joseph Abi Jaoude, Ramez Kouzy +12 more

Survival-inferred fragility of statistical significance in phase III oncology trials

npj Precision Oncology(2025)10.1038/s41698-025-01024-2

N/A

0DataRank · unranked

1 citations

Yufei Liu, Pavlos Msaouel, Timothy A. Lin, Alex Koong, Christine Lin +12 more

Survival-Inferred Fragility of Statistical Significance in Phase III Oncology Trials

medRxiv(2025)10.1101/2025.01.11.25320398

N/A

0DataRank · unranked

0 citations

Yufei Liu, Pavlos Msaouel, Timothy A. Lin, Alex Koong, Christine Lin +12 more

413 | PROGRESSION PATTERNS BY POSITRON EMISSION TOMOGRAPHY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA AFTER CAR T CELL THERAPY: POTENTIAL ROLE FOR RADIOTHERAPY?

Hematological Oncology(2025)10.1002/hon.70094_413

N/A

0DataRank · unranked

0 citations

Harper Hubbeling, B. Fregonese, G. Cederquist, Nikhil P. Mankuzhy, Roshal R. Patel +8 more

Phase 1/2 Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage SCLC

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.08.022

N/A

0DataRank · unranked

98 citations

John V. Heymach, Chunxiao Guo, Hari Menon, Katherine Klein, Taylor R. Cushman +19 more

De-intensification of therapy in human papillomavirus associated oropharyngeal cancer: A systematic review of prospective trials

Oral Oncology(2020)10.1016/j.oraloncology.2020.104608

N/A

0DataRank · unranked

48 citations

Ethan B. Ludmir, Alexander Augustyn, Nicholas G. Zaorsky, Eric J. Lehrer, Rohith Ryali +5 more

Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activity

Translational Oncology(2020)10.1016/j.tranon.2020.100983

N/A

0DataRank · unranked

29 citations

Hampartsoum B. Barsoumian, Duygu Sezen, Vivek Verma, Roshal R. Patel, Mark Wasley +12 more

Transparency in reporting of phase 3 cancer clinical trial results

Acta Oncologica(2020)10.1080/0284186x.2020.1856410

N/A

0DataRank · unranked

8 citations

Vivek Verma, Clifton D. Fuller, Zachary R. McCaw, Ethan B. Ludmir, Roshal R. Patel